| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |